Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7KAC

Crystal structure of HPK1 (MAP4K1) kinase in complex with 5-{[4-{[(1S)-2-HYDROXY-1-PHENYLETHYL]AMINO}-5-(1,3,4-OXADIAZOL-2-YL)PYRIMIDIN-2-YL]AMINO}-3,3-DIMETHYL-2-BENZOFURAN-1(3H)-ONE

Summary for 7KAC
Entry DOI10.2210/pdb7kac/pdb
DescriptorIsoform 2 of Mitogen-activated protein kinase kinase kinase kinase 1, 5-{[4-{[(1S)-2-hydroxy-1-phenylethyl]amino}-5-(1,3,4-oxadiazol-2-yl)pyrimidin-2-yl]amino}-3,3-dimethyl-2-benzofuran-1(3H)-one (3 entities in total)
Functional Keywordskinase, map4k1, hpk1, serine/threonine-protein kinase, hematopoietic progenitor kinase, mapk/erk kinase kinase kinase 1, mek kinase kinase 1, mekkk1, nucleotide-binding, phosphoprotein, transferase-transferase inhibitor complex, transferase/transferase inhibitor
Biological sourceHomo sapiens (Human)
Total number of polymer chains2
Total formula weight77024.58
Authors
Sheriff, S. (deposition date: 2020-09-30, release date: 2021-01-13, Last modification date: 2023-10-18)
Primary citationLau, W.L.,Pearce, B.,Malakian, H.,Rodrigo, I.,Xie, D.,Gao, M.,Marsilio, F.,Chang, C.,Ruzanov, M.,Muckelbauer, J.K.,Newitt, J.A.,Lipovsek, D.,Sheriff, S.
Using yeast surface display to engineer a soluble and crystallizable construct of hematopoietic progenitor kinase 1 (HPK1).
Acta Crystallogr.,Sect.F, 77:22-28, 2021
Cited by
PubMed Abstract: Hematopoietic progenitor kinase 1 (HPK1) is an intracellular kinase that plays an important role in modulating tumor immune response and thus is an attractive target for drug discovery. Crystallization of the wild-type HPK1 kinase domain has been hampered by poor expression in recombinant systems and poor solubility. In this study, yeast surface display was applied to a library of HPK1 kinase-domain variants in order to select variants with an improved expression level and solubility. The HPK1 variant with the most improved properties contained two mutations, crystallized readily in complex with several small-molecule inhibitors and provided valuable insight to guide structure-based drug design. This work exemplifies the benefit of yeast surface display towards engineering crystallizable proteins and thus enabling structure-based drug discovery.
PubMed: 33439152
DOI: 10.1107/S2053230X20016015
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.85 Å)
Structure validation

227111

数据于2024-11-06公开中

PDB statisticsPDBj update infoContact PDBjnumon